Search

everythinglearnresearchcommunity

for

Search:↓

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Some drugs can cause hair loss, increase hair growth, or change hair color, but stopping the drug usually reverses these effects.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Antibiotics often cause skin reactions, making them a major health concern.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Side effects of drugs can lead to the discovery of new treatments.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Biologics for severe asthma have known side effects, but some new risks need more study.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.